Statin Use May Lower Risk for Pancreatic Cancer

Share this content:
Statin use may be associated with a decreased risk of pancreatic cancer in patients with type 2 diabetes.
Statin use may be associated with a decreased risk of pancreatic cancer in patients with type 2 diabetes.

Statin use may be associated with a decreased risk of pancreatic cancer in patients with type 2 diabetes, according to a Taiwanese population study published in the International Journal of Cancer.1

In a retrospective, population-based cohort study, researchers led by Mei-Jyh Chen, MS, MD, of the National Taiwan University College of Public Health in Taipei looked at 1,140,617 patients with type 2 diabetes from the National Health Insurance Research database from 1997 to 2010.

“The aim of this study was to determine whether statin use exerts a protective effect against pancreatic cancer in type 2 diabetes patients,” the authors wrote.

In total, 2,341 patients with newly-diagnosed pancreatic cancer were identified in the diabetic cohort upon follow-up.

RELATED: Tiny Particles May Serve as Non-Invasive Tool for Detecting Early Stage Pancreatic Cancer

Among the observed patient population, 450,282 patients were defined as statin users, and 0.14% of them had pancreatic cancer, while 690,335 were defined as non-statin users with 0.25% who had pancreatic cancer.

Upon adjusting for multiple confounders, statin use was found to be linked with a significantly decreased risk of pancreatic cancer, as well as a dose-effect for risk of pancreatic cancer.

Reference

1. Chen M-J, Tsan Y-T, Liou J-M, et al. Statins and the risk of pancreatic cancer in type 2 diabetic patients—a population-based cohort study. [published online ahead of print August 31, 2015]. Int. J. Cancer. doi: 10.1002/ijc.29813. 

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters